Ionis Pharmaceuticals Inc
General ticker "IONS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.4B
Ionis Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -19.6%.
Estimated limits based on current volatility of 2.1%: low 35.23$, high 36.71$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [36.41$, 63.52$]
- 2024-12-30 to 2025-12-30 estimated range: [40.00$, 68.41$]
Financial Metrics affecting the IONS estimates:
- Negative: Non-GAAP EPS, $ of -2.56 <= 0.10
- Negative: Operating profit margin, % of -30.99 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -4.13 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: -3.48 < Investing cash flow per share, $ of -1.50
Short-term IONS quotes
Long-term IONS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $810.46MM | $587.37MM | $787.65MM |
| Operating Expenses | $840.64MM | $997.56MM | $1,141.38MM |
| Operating Income | $-30.19MM | $-410.19MM | $-353.73MM |
| Non-Operating Income | $1.04MM | $152.21MM | $19.77MM |
| Interest Expense | $4.30MM | $8.12MM | $0.00MM |
| R&D Expense | $643.00MM | $833.00MM | $899.62MM |
| Income(Loss) | $-29.15MM | $-257.99MM | $-333.96MM |
| Taxes | $-0.55MM | $11.74MM | $32.32MM |
| Profit(Loss) | $-28.60MM | $-269.72MM | $-366.29MM |
| Stockholders Equity | $771.74MM | $572.89MM | $386.69MM |
| Inventory | $24.81MM | $22.03MM | $28.43MM |
| Assets | $2,611.69MM | $2,533.88MM | $2,990.07MM |
| Operating Cash Flow | $30.80MM | $-274.37MM | $-307.51MM |
| Capital expenditure | $17.90MM | $20.10MM | $28.01MM |
| Investing Cash Flow | $194.91MM | $-262.64MM | $-214.13MM |
| Financing Cash Flow | $245.93MM | $-55.30MM | $644.08MM |
| Earnings Per Share* | $-0.21 | $-1.90 | $-2.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.